Eli Lilly (LLY), Boehringer Ingelheim Note Presentation of Strong Jardiance Data in Cardiovascular Death Reduction for T2D Patients
Go back to Eli Lilly (LLY), Boehringer Ingelheim Note Presentation of Strong Jardiance Data in Cardiovascular Death Reduction for T2D PatientsLilly (Eli) & Co. (NYSE: LLY) | Delayed: 745.69 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $745.69 | 52 Week High | $88.16 | |||
Open | $745.69 | 52 Week Low | $67.88 | |||
Day High | $745.69 | P/E | 172.61 | |||
Day Low | $745.69 | EPS | $4.32 | |||
Volume | 7,555 |